GL1X · GenesisL1 explorer

UniProt P0DTC2

spike glycoprotein (P0DTC2)

spike glycoprotein (UniProt P0DTC2): 2,619 experimental structures on GenesisL1, 43 ligands bound, 16,782 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P0DTC2
Protein
spike glycoprotein
Experimental structures
2,619
Predicted models
0
Ligands
43
Pockets
16,782 · 1,257 records with a druggable one

Structures

2,619 records of P0DTC2 in the MolNFT archive: 2619 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
6LVNStructure of the 2019-nCoV HR2 Domainx-ray diffractionA, B, C, D——
6LVNStructure of the 2019-ncov HR2 domainx-ray diffractionA, B, C, D——
6LXTStructure of post fusion core of 2019-nCoV S2 subunitx-ray diffractionA, B, C, D, E, FZN5 (best 0.73)
6LXTStructure of post fusion core of 2019-ncov S2 subunitx-ray diffractionA, B, C, D, E, FZN—
6LZGStructure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2x-ray diffractionBNAG2 (best 0.72)
6LZGStructure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2x-ray diffractionBNAG—
6M0JCrystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2x-ray diffractionENAG3 (best 0.70)
6M0JCrystal structure of SARS-cov-2 spike receptor-binding domain bound with ACE2x-ray diffractionENAG—
6M17The 2019-nCoV RBD/ACE2-B0AT1 complexelectron microscopyE, FNAG5 (best 0.71)
6M17The 2019-ncov RBD/ACE2-B0AT1 complexelectron microscopyE, FNAG—
6M1VCrystal structure of post fusion core of 2019-nCoV S2 subunitx-ray diffractionA——
6M1VCrystal structure of post fusion core of 2019-ncov S2 subunitx-ray diffractionA——
6VSBPrefusion 2019-ncov spike glycoprotein with a single receptor-binding domain upelectron microscopyA, B, CNAG—
6VW1Structure of SARS-cov-2 chimeric receptor-binding domain complexed with its receptor human ACE2x-ray diffractionE, FBMA, NAG—
6VXXStructure of the SARS-CoV-2 spike glycoprotein (closed state)electron microscopyA, B, CNAG20 (best 0.87)
6VXXStructure of the SARS-cov-2 spike glycoprotein (closed state)electron microscopyA, B, CNAG—
6VYBSARS-CoV-2 spike ectodomain structure (open state)electron microscopyA, B, CNAG20 (best 0.86)
6VYBSARS-cov-2 spike ectodomain structure (open state)electron microscopyA, B, CNAG—
6W41Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022x-ray diffractionCNAG5 (best 0.41)
6W41Crystal structure of SARS-cov-2 receptor binding domain in complex with human antibody CR3022x-ray diffractionCNAG—
6WPSStructure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab…electron microscopyA, B, ENAG20 (best 0.86)
6WPSStructure of the SARS-cov-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab…electron microscopyA, B, ENAG—
6WPTStructure of the SARS-cov-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab…electron microscopyA, B, CNAG—
6X29SARS-CoV-2 rS2d Down State Spike Protein Trimerelectron microscopyA, B, C—20 (best 0.88)
6X29SARS-cov-2 RS2D down state spike protein trimerelectron microscopyA, B, C——
6X2ASARS-CoV-2 u1S2q 1-RBD Up Spike Protein Trimerelectron microscopyA, B, C—20 (best 0.83)
6X2ASARS-cov-2 U1S2Q 1-rbd up spike protein trimerelectron microscopyA, B, C——
6X2BSARS-CoV-2 u1S2q 2-RBD Up Spike Protein Trimerelectron microscopyA, B, C—20 (best 0.84)
6X2BSARS-cov-2 U1S2Q 2-rbd up spike protein trimerelectron microscopyA, B, C——
6X2CSARS-CoV-2 u1S2q All Down RBD State Spike Protein Trimerelectron microscopyA, B, C—20 (best 0.85)
6X2CSARS-cov-2 U1S2Q all down rbd state spike protein trimerelectron microscopyA, B, C——
6X45SARS-CoV2 spike glycoprotein N-terminal heptad repeat domain + SARS-CoV2(QEYKKEKE)x-ray diffractionE, D, C, F, B, A—1 (best 0.72)
6X45SARS-COV2 spike glycoprotein N-terminal heptad repeat domain + SARS- COV2(QEYKKEKE)x-ray diffractionE, D, C, F, B, ANH2—
6X6PCharacterization of the SARS-cov-2 S protein: biophysical, biochemical, structural, and antigenic…electron microscopyA, B, CNAG—
6X79Prefusion SARS-CoV-2 S ectodomain trimer covalently stabilized in the closed conformationelectron microscopyA, B, CNAG20 (best 0.88)
6X79Prefusion SARS-cov-2 S ectodomain trimer covalently stabilized in the closed conformationelectron microscopyA, B, CNAG—
6XC2Crystal structure of SARS-cov-2 receptor binding domain in complex with neutralizing antibody CC12.1x-ray diffractionA, ZNAG—
6XC3Crystal structure of SARS-cov-2 receptor binding domain in complex with antibodies CC12.1 and CR3022x-ray diffractionCNAG—
6XC4Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3x-ray diffractionA, ZNAG4 (best 0.71)
6XC4Crystal structure of SARS-cov-2 receptor binding domain in complex with neutralizing antibody CC12.3x-ray diffractionA, ZNAG—
6XC7Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022x-ray diffractionANAG7 (best 0.66)
6XC7Crystal structure of SARS-cov-2 receptor binding domain in complex with antibodies CC12.3 and CR3022x-ray diffractionANAG—
6XCMStructure of the SARS-cov-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab…electron microscopyA, B, CNAG, FUC—
6XCNStructure of the SARS-cov-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab…electron microscopyA, C, ENAG—
6XDGComplex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodieselectron microscopyENAG6 (best 0.72)
6XDGComplex of SARS-cov-2 receptor binding domain with the Fab fragments of two neutralizing antibodieselectron microscopyENAG—
6XE1Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a potent neutralizing…x-ray diffractionENAG2 (best 0.73)
6XE1Structure of SARS-cov-2 spike protein receptor binding domain in complex with a potent neutralizing…x-ray diffractionENAG—
6XEYCryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4electron microscopyA, B, CNAG, BMA14 (best 0.83)
6XEYCryo-EM structure of the SARS-cov-2 spike glycoprotein bound to Fab 2- 4electron microscopyA, B, CNAG—
6XF5Cryo-EM structure of a biotinylated SARS-cov-2 spike probe in the prefusion state (rbds down)electron microscopyA, B, CNAG—
6XF6Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)electron microscopyA, B, CNAG20 (best 0.85)
6XF6Cryo-EM structure of a biotinylated SARS-cov-2 spike probe in the prefusion state (1 rbd up)electron microscopyA, B, CNAG—
6XKLSARS-cov-2 hexapro S one rbd upelectron microscopyA, B, CNAG—
6XKPCrystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody…x-ray diffractionA, BNAG, SO49 (best 0.75)
6XKPCrystal structure of SARS-cov-2 receptor binding domain in complex with neutralizing antibody…x-ray diffractionA, BNAG, SO4—
6XKQCrystal structure of SARS-cov-2 receptor binding domain in complex with neutralizing antibody…x-ray diffractionANAG—
6XLUStructure of SARS-CoV-2 spike at pH 4.0electron microscopyA, B, CNAG20 (best 0.87)
6XLUStructure of SARS-cov-2 spike at pH 4.0electron microscopyA, B, CNAG—
6XM0Consensus structure of SARS-CoV-2 spike at pH 5.5electron microscopyA, B, CNAG20 (best 0.86)

2,559 records more on the page itself.

Ligands

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 2,028 records
  • FUC · alpha-L-fucopyranose · in 122 records
  • BMA · beta-D-mannopyranose · in 61 records
  • SO4 · Sulfate ion · in 54 records
  • MAN · alpha-D-mannopyranose · in 39 records
  • CL · Chloride ion · in 38 records
  • EIC · Linoleic acid · in 31 records
  • BLA · Biliverdine IX alpha · in 28 records
  • PO4 · Phosphate ion · in 10 records
  • NA · Sodium ion · in 7 records
  • CA · Calcium ion · in 5 records
  • NO3 · Nitrate ion · in 5 records
  • GAL · beta-D-galactopyranose · in 4 records
  • ZN · Zinc ion · in 4 records
  • BR · Bromide ion · in 3 records
  • IDU · 2-O-sulfo-beta-L-altropyranuronic acid · in 3 records
  • MG · Magnesium ion · in 3 records
  • NH2 · Amino group · in 3 records
  • VCG · 2-hydroxyethyl 2-deoxy-3,5-bis-O-(2-hydroxyethyl)-6-O-(2-{[(9E)-octadec-9-enoyl]oxy}ethyl)-alpha-L-xylo-hexofuranoside · in 3 records
  • ACE · Acetyl group · in 2 records
  • BLR · 3-[5-[(Z)-(4-ethenyl-3-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-2-[[5-[(Z)-(3-ethenyl-4-methyl-5-oxidanylidene-pyrrol-2-ylidene)methyl]-3-(3-hydroxy-3-oxopropyl)-4-methyl-1H-pyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid · in 2 records
  • CD · Cadmium ion · in 2 records
  • DHL · 2-amino-ethanethiol · in 2 records
  • ELA · 9-octadecenoic acid · in 2 records
  • GE9 · 2,3,5-tris(iodanyl)benzamide · in 2 records
  • K · Potassium ion · in 2 records
  • NDG · 2-acetamido-2-deoxy-alpha-D-glucopyranose · in 2 records
  • PRO · Proline · in 2 records
  • REA · Retinoic acid · in 2 records
  • SIA · N-acetyl-alpha-neuraminic acid · in 2 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.